日本ケミファの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/08/03 | 1,855 | 1,859 | 1,840 | 1,840 | -15 | -0.8% | 5,800 |
2023/08/02 | 1,896 | 1,896 | 1,851 | 1,855 | -41 | -2.2% | 2,400 |
2023/08/01 | 1,870 | 1,925 | 1,859 | 1,896 | +38 | +2% | 7,400 |
2023/07/31 | 1,868 | 1,869 | 1,851 | 1,858 | +8 | +0.4% | 4,100 |
2023/07/28 | 1,908 | 1,925 | 1,850 | 1,850 | -77 | -4% | 18,400 |
2023/07/27 | 1,929 | 1,933 | 1,911 | 1,927 | ±0 | ±0% | 4,300 |
2023/07/26 | 1,905 | 1,928 | 1,905 | 1,927 | +15 | +0.8% | 3,800 |
2023/07/25 | 1,912 | 1,919 | 1,897 | 1,912 | ±0 | ±0% | 2,800 |
2023/07/24 | 1,894 | 1,913 | 1,876 | 1,912 | +42 | +2.2% | 5,900 |
2023/07/21 | 1,869 | 1,897 | 1,869 | 1,870 | -10 | -0.5% | 3,100 |
2023/07/20 | 1,863 | 1,901 | 1,863 | 1,880 | +15 | +0.8% | 2,900 |
2023/07/19 | 1,863 | 1,865 | 1,839 | 1,865 | +32 | +1.7% | 2,400 |
2023/07/18 | 1,869 | 1,869 | 1,833 | 1,833 | -38 | -2% | 4,600 |
2023/07/14 | 1,901 | 1,901 | 1,871 | 1,871 | -36 | -1.9% | 5,500 |
2023/07/13 | 1,902 | 1,911 | 1,895 | 1,907 | +5 | +0.3% | 5,200 |
2023/07/12 | 1,901 | 1,912 | 1,901 | 1,902 | -1 | -0.1% | 3,800 |
2023/07/11 | 1,929 | 1,929 | 1,901 | 1,903 | -26 | -1.3% | 5,000 |
2023/07/10 | 1,915 | 1,936 | 1,910 | 1,929 | +35 | +1.8% | 5,000 |
2023/07/07 | 1,902 | 1,904 | 1,890 | 1,894 | -8 | -0.4% | 3,700 |
2023/07/06 | 1,917 | 1,917 | 1,902 | 1,902 | -14 | -0.7% | 1,900 |
2023/07/05 | 1,919 | 1,938 | 1,910 | 1,916 | -10 | -0.5% | 3,500 |
2023/07/04 | 1,931 | 1,940 | 1,911 | 1,926 | -6 | -0.3% | 3,500 |
2023/07/03 | 1,913 | 1,933 | 1,913 | 1,932 | +12 | +0.6% | 1,200 |
2023/06/30 | 1,925 | 1,925 | 1,907 | 1,920 | +25 | +1.3% | 3,500 |
2023/06/29 | 1,930 | 1,930 | 1,895 | 1,895 | -38 | -2% | 7,100 |
2023/06/28 | 1,920 | 1,939 | 1,920 | 1,933 | +26 | +1.4% | 3,900 |
2023/06/27 | 1,899 | 1,913 | 1,880 | 1,907 | +8 | +0.4% | 7,700 |
2023/06/26 | 1,866 | 2,112 | 1,849 | 1,899 | +42 | +2.3% | 45,400 |
2023/06/23 | 1,854 | 1,863 | 1,853 | 1,857 | +11 | +0.6% | 2,900 |
2023/06/22 | 1,856 | 1,856 | 1,846 | 1,846 | +14 | +0.8% | 3,200 |
2023/06/21 | 1,825 | 1,859 | 1,825 | 1,832 | +7 | +0.4% | 2,700 |
2023/06/20 | 1,835 | 1,836 | 1,825 | 1,825 | -10 | -0.5% | 1,400 |
2023/06/19 | 1,835 | 1,835 | 1,829 | 1,835 | +11 | +0.6% | 1,000 |
2023/06/16 | 1,810 | 1,825 | 1,810 | 1,824 | +6 | +0.3% | 4,000 |
2023/06/15 | 1,821 | 1,839 | 1,818 | 1,818 | -10 | -0.5% | 3,300 |
2023/06/14 | 1,833 | 1,833 | 1,825 | 1,828 | +7 | +0.4% | 1,800 |
2023/06/13 | 1,818 | 1,832 | 1,817 | 1,821 | +6 | +0.3% | 2,800 |
2023/06/12 | 1,820 | 1,820 | 1,815 | 1,815 | ±0 | ±0% | 300 |
2023/06/09 | 1,823 | 1,823 | 1,815 | 1,815 | -8 | -0.4% | 3,800 |
2023/06/08 | 1,818 | 1,824 | 1,816 | 1,823 | +5 | +0.3% | 1,800 |
2023/06/07 | 1,826 | 1,830 | 1,817 | 1,818 | -10 | -0.5% | 3,000 |
2023/06/06 | 1,825 | 1,828 | 1,820 | 1,828 | ±0 | ±0% | 1,000 |
2023/06/05 | 1,825 | 1,831 | 1,821 | 1,828 | -1 | -0.1% | 3,100 |
2023/06/02 | 1,825 | 1,834 | 1,818 | 1,829 | +3 | +0.2% | 3,900 |
2023/06/01 | 1,834 | 1,838 | 1,820 | 1,826 | -1 | -0.1% | 2,200 |
2023/05/31 | 1,826 | 1,836 | 1,826 | 1,827 | -1 | -0.1% | 2,600 |
2023/05/30 | 1,850 | 1,850 | 1,828 | 1,828 | -12 | -0.7% | 3,800 |
2023/05/29 | 1,853 | 1,853 | 1,840 | 1,840 | -14 | -0.8% | 3,400 |
2023/05/26 | 1,847 | 1,862 | 1,847 | 1,854 | +7 | +0.4% | 6,100 |
2023/05/25 | 1,845 | 1,858 | 1,841 | 1,847 | +2 | +0.1% | 3,100 |
201~
250
件表示中 / 3466件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日ケミファ | 155,600円 | +2.5% | - | 3.21% | 93.57倍 | 0.31倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
シンバイオ | 15,000円 | -53.1% | - | 0.00% | - | 0.99倍 |
|
他社から新薬候補導入し開発、製品化。抗ウイルス薬「ブリンシドフォビル(BCV)」開発注力 |
カルナバイオ | 38,800円 | -43.1% | - | 0.00% | - | 1.72倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
カイオム | 11,500円 | +2.6% | - | 0.00% | - | 5.69倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
メドレックス | 15,300円 | +1424.1% | - | 0.00% | - | 3.32倍 |
|
経皮吸収型製剤技術に強い創薬ベンチャー。治験は米国で。先端分野マイクロニードルに挑戦 |
市場注目の銘柄
チャート関連のコラム